APA

Burnett A. K., Hills R. K., Green C., Jenkinson S., Koo K., Patel Y., Guy C., Gilkes A., Milligan D. W., Goldstone A. H., Prentice A. G., Wheatley K., Linch D. C. & Gale R. E. (20100305). The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. : Blood.

Chicago

Burnett Alan K, Hills Robert K, Green Claire, Jenkinson Sarah, Koo Kenneth, Patel Yashma, Guy Carol, Gilkes Amanda, Milligan Donald W, Goldstone Anthony H, Prentice Archibald G, Wheatley Keith, Linch David C and Gale Rosemary E. 20100305. The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. : Blood.

Harvard

Burnett A. K., Hills R. K., Green C., Jenkinson S., Koo K., Patel Y., Guy C., Gilkes A., Milligan D. W., Goldstone A. H., Prentice A. G., Wheatley K., Linch D. C. and Gale R. E. (20100305). The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. : Blood.

MLA

Burnett Alan K, Hills Robert K, Green Claire, Jenkinson Sarah, Koo Kenneth, Patel Yashma, Guy Carol, Gilkes Amanda, Milligan Donald W, Goldstone Anthony H, Prentice Archibald G, Wheatley Keith, Linch David C and Gale Rosemary E. The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. : Blood. 20100305.